Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Biwei Cao"'
Autor:
Gerald Wallace, Ronak Kundalia, Ethan Vallebuona, Biwei Cao, Youngchul Kim, Peter Forsyth, Aixa Soyano, Inna Smalley, Yolanda Pina
Publikováno v:
Breast Cancer Research, Vol 26, Iss 1, Pp 1-12 (2024)
Abstract Background Breast cancer-related leptomeningeal disease (BC-LMD) is a dire diagnosis for 5–8% of patients with breast cancer (BC). We conducted a retrospective review of BC-LMD patients diagnosed at Moffitt Cancer Center from 2011 to 2020,
Externí odkaz:
https://doaj.org/article/fbe9db6e0a42479c95574a8a573ceaaa
Autor:
Sanjay Chandrasekhar, Matthew Perez, Zurain Niaz, Jahanzaib Ekram, Neelam Lal, Sarah Koly, Biwei Cao, Jonathan S. Zager, Mohammed Alomar
Publikováno v:
Cancer Control, Vol 31 (2024)
Background Percutaneous Hepatic Perfusion (PHP) is a liver directed regional therapy recently FDA approved for metastatic uveal melanoma to the liver involving percutaneous isolation of liver, saturation of the entire liver with high-dose chemotherap
Externí odkaz:
https://doaj.org/article/b57418c0f6174984b443e53dc7deea13
Publikováno v:
PLoS ONE, Vol 19, Iss 5, p e0301917 (2024)
Data sharing is highly advocated in the scientific community, with numerous organizations, funding agencies, and journals promoting transparency and collaboration. However, limited research exists on actual data sharing practices. We conducted a comp
Externí odkaz:
https://doaj.org/article/d4446812392540a893a0b33773d34c6f
Publikováno v:
Frontiers in Aging Neuroscience, Vol 15 (2023)
BackgroundParkinson’s disease is a neurological disorder that can cause gait disturbance, leading to mobility issues and falls. Early diagnosis and prediction of freeze episodes are essential for mitigating symptoms and monitoring the disease.Objec
Externí odkaz:
https://doaj.org/article/75aeecbaee46413c87db16354c95d3a0
Autor:
Lingbin Meng1,2, Biwei Cao2, Rui Ji, Dung-Tsa Chen2, Laber, Damian A.3, Shafique, Michael4 michael.shafique@moffitt.org
Publikováno v:
Journal of Cancer. 2023, Vol. 14 Issue 17, p3169-3175. 7p.
Autor:
Qiaochu Zhu, Jing Zhou, Yijie Zhang, Hai Huang, Jie Han, Biwei Cao, Dandan Xu, Yan Zhao, Gang Chen
Publikováno v:
Frontiers in Neuroscience, Vol 17 (2023)
ObjectiveAmyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder affecting the upper and lower motor neurons. Though the pathogenesis of ALS is still unclear, exploring the associations between risk factors and ALS can provide relia
Externí odkaz:
https://doaj.org/article/fb269d5cb3f24877a6090ac19bb07a65
Publikováno v:
iScience, Vol 26, Iss 2, Pp 105915- (2023)
Summary: Cancer prognosis prediction is critical to the clinical decision-making process. Currently, the high availability of transcriptome datasets allows us to extract the gene modules with promising prognostic values. However, the biomarker identi
Externí odkaz:
https://doaj.org/article/195edd9830344e778d51cb5c73286ef8
Autor:
Timothy Hembree, Olga Theou, Sarah Thirlwell, Richard R. Reich, Biwei Cao, Marina Sehovic, Misbahuddin Syed, Neha Verma, Thu‐Cuc Nguyen, Dinesh Keerty, Jaqueline Wesolow, Viktoriya Koverzhenko, Martine Extermann, Jessica Huang, Asha Ramsakal
Publikováno v:
Cancer Medicine, Vol 10, Iss 17, Pp 5765-5774 (2021)
Abstract Background Frailty is a state of increased vulnerability to stressors, and predicts risk of adverse outcomes, such as mortality. Frailty can be defined by a frailty index (FI) using an accumulation of deficits approach. An FI comprised of 20
Externí odkaz:
https://doaj.org/article/0ff440e8fe544bfda013a94ce373d5d8
Autor:
Judith D Goldberg, Joseph Markowitz, Jeffrey Weber, Ragini Kudchadkar, Tomas Kirchhoff, Anna Pavlick, Zeynep Eroglu, Melinda Vassallo, David M Woods, Andrew S Brohl, Nikhil I Khushalani, Alison Richards, Younchul Kim, Biwei Cao, Robert Ferguson, Kelsey R Monson, Carol M Amato, Paulo Burke, Ann Strange, Emily Monk, Geoffrey Thomas Gibney
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 11 (2022)
Background Adjuvant therapy for high-risk resected melanoma with programmed cell-death 1 blockade results in a median relapse-free survival (RFS) of 5 years. The addition of low dose ipilimumab (IPI) to a regimen of adjuvant nivolumab (NIVO) in Check
Externí odkaz:
https://doaj.org/article/1c7d034388cd4ebbbabd2100271c621e
Publikováno v:
BMC Bioinformatics, Vol 21, Iss 1, Pp 1-21 (2020)
Abstract Background Cancer is a highly heterogeneous disease with varying responses to anti-cancer drugs. Although several attempts have been made to predict the anti-cancer therapeutic responses, there remains a great need to develop highly accurate
Externí odkaz:
https://doaj.org/article/9818177548f04f2ea35bb79916f97b5c